Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Plasencia

7 clinical trials in Plasencia, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Plasencia at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Plasencia

Open in trial search
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Quizartinib Dihydrochloride
  • Sponsor:Fundacion PETHEMA
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:ALLERGEN EXTRACTS
  • Sponsor:Inmunotek S.L.

Onychomycosis

Not recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:CICLOPIROX
  • Sponsor:Laboratorio Reig Jofre S.A.

Parkinson's disease

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Plasencia

What the registry says about research in the country

01 Autoimmune Disorders

Innovative research focusing on ANCA-associated vasculitis, evaluating new therapeutic approaches for managing this rare autoimmune condition. Studies aim to achieve sustained disease remission through targeted treatment interventions.

  • Vasculitis Management
  • Autoimmune Disease Therapy
  • Remission Studies

Current trials are exploring advanced therapeutic options to improve patient outcomes in autoimmune vasculitis.

02 Neurodegenerative Disorders

Groundbreaking clinical research targeting early Parkinson's disease, investigating innovative treatments to address motor progression. These studies focus on evaluating new therapeutic agents for better disease management.

  • Motor Function Assessment
  • Disease Progression
  • Early Intervention Strategies

Trials are designed to explore novel approaches in slowing the progression of early-stage Parkinson's disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.